Arecor Therapeutics (LSE:AREC) Price-to-Tangible-Book : 7.22 (As of May. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics Price-to-Tangible-Book?

As of today (2024-05-21), Arecor Therapeutics's share price is £1.465. Arecor Therapeutics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was £0.20. Hence, Arecor Therapeutics's Price to Tangible Book Ratio of today is 7.22.

The historical rank and industry rank for Arecor Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

LSE:AREC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.23 Med: 6.02 Max: 8.99
Current: 7.33

During the past 7 years, Arecor Therapeutics's highest Price to Tangible Book Ratio was 8.99. The lowest was 5.23. And the median was 6.02.

LSE:AREC's Price-to-Tangible-Book is ranked worse than
81.46% of 1230 companies
in the Biotechnology industry
Industry Median: 2.78 vs LSE:AREC: 7.33

A closely related ratio is called PB Ratio. As of today, Arecor Therapeutics's share price is £1.465. Arecor Therapeutics's Book Value per Sharefor the quarter that ended in Dec. 2023 was £0.31. Hence, Arecor Therapeutics's P/B Ratio of today is 4.71.

Arecor Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Arecor Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arecor Therapeutics Price-to-Tangible-Book Chart

Arecor Therapeutics Annual Data

Trend

May17

May18

May19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

6.02

5.23

8.99

Arecor Therapeutics Semi-Annual Data
	May18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial					6.02	6.41	5.23	7.10	8.99

Competitive Comparison of Arecor Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Arecor Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arecor Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arecor Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Arecor Therapeutics's Price-to-Tangible-Book falls into.

Arecor Therapeutics Price-to-Tangible-Book Calculation

Arecor Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.465	/	0.203
	=	7.22

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Arecor Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Arecor Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Arecor Therapeutics (LSE:AREC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (LSE:AREC) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

6UI:Germany

Address

Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL

Website

https://www.arecor.com

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, the Rest of Europe, the USA, India, and the Rest of the World, out of which the majority is from the UK.